Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
IDrugs. 2003 May;6(5):479-85.

SPM-927 (Schwarz Pharma).

Author information

  • 1The Cleveland Clinic Foundation, Departments of Neurology/Pharmacy, 9500 Euclid Ave-S51, Cleveland, OH 44195, USA. cahovinga@aol.com

Abstract

Schwarz Pharma, under license from Harris FRC, is developing SPM-927, synthesized by researchers at the University of Houston, for the potential treatment of epilepsy and neuropathic pain.

PMID:
12789603
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk